HomeAI · summaries
Storia in 5 fonti
Abivax aims to set cancer concerns with ulcerative colitis drug to rest
Abivax says new Phase 3 data show cancer rates within expected range for its UC drug obefazimod, though Jefferies flags lingering FDA risk.
Confronto fonti
5 prospettive sulla stessa storiaTimeline cronologica
- ·
statnews.com
Abivax seeks to ease safety concerns with new data, boosting shares
Safety concerns tied to Abivax's experimental bowel disease drug tanked company shares just weeks ago. But a new analysis sent them climbing.
- ·
euronews.com
Abivax rallies 36% as trial data ease safety fears over obefazimod
French biotech company Abivax said new clinical trial data supports the safety and effectiveness of its experimental ulcerative colitis treatment.
